Cargando…

Repurposing of FDA-approved drugs against cancer – focus on metastasis

Detalles Bibliográficos
Autores principales: Ozsvári, Béla, Lamb, Rebecca, Lisanti, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925811/
https://www.ncbi.nlm.nih.gov/pubmed/27038638
http://dx.doi.org/10.18632/aging.100941
_version_ 1782439994364788736
author Ozsvári, Béla
Lamb, Rebecca
Lisanti, Michael P.
author_facet Ozsvári, Béla
Lamb, Rebecca
Lisanti, Michael P.
author_sort Ozsvári, Béla
collection PubMed
description
format Online
Article
Text
id pubmed-4925811
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-49258112016-07-01 Repurposing of FDA-approved drugs against cancer – focus on metastasis Ozsvári, Béla Lamb, Rebecca Lisanti, Michael P. Aging (Albany NY) Editorial Impact Journals LLC 2016-04-02 /pmc/articles/PMC4925811/ /pubmed/27038638 http://dx.doi.org/10.18632/aging.100941 Text en Copyright: © 2016 Ozsvári et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Ozsvári, Béla
Lamb, Rebecca
Lisanti, Michael P.
Repurposing of FDA-approved drugs against cancer – focus on metastasis
title Repurposing of FDA-approved drugs against cancer – focus on metastasis
title_full Repurposing of FDA-approved drugs against cancer – focus on metastasis
title_fullStr Repurposing of FDA-approved drugs against cancer – focus on metastasis
title_full_unstemmed Repurposing of FDA-approved drugs against cancer – focus on metastasis
title_short Repurposing of FDA-approved drugs against cancer – focus on metastasis
title_sort repurposing of fda-approved drugs against cancer – focus on metastasis
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925811/
https://www.ncbi.nlm.nih.gov/pubmed/27038638
http://dx.doi.org/10.18632/aging.100941
work_keys_str_mv AT ozsvaribela repurposingoffdaapproveddrugsagainstcancerfocusonmetastasis
AT lambrebecca repurposingoffdaapproveddrugsagainstcancerfocusonmetastasis
AT lisantimichaelp repurposingoffdaapproveddrugsagainstcancerfocusonmetastasis